Increased long-term survival among patients with hepatocellular carcinoma after implementation of model for end-stage liver disease score

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 9, 2014, Pages

  Wong, Robert J ^a,c   Devaki, Pardha ^d   Nguyen, Long ^a   Cheung, Ramsey ^a,c   Cho Phan, Cheryl ^b   Nguyen, Mindie H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Liver cancer; Racial disparities; Resource allocation; SEER

Indexed keywords

ADULT; ARTICLE; ASIAN; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; SURVIVAL TIME; TRANSPLANTATION; TREND STUDY; AGE DISTRIBUTION; AGED; CLINICAL FEATURE; END STAGE LIVER DISEASE; ETHNIC GROUP; LIVER TRANSPLANTATION; OVERALL SURVIVAL; SEX DIFFERENCE; SURVIVAL RATE; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; MIDDLE AGED; MORTALITY; SEVERITY OF ILLNESS INDEX; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84906791183     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.008     Document Type: Article

References (30)

1. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
2. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
3. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
4. Cancer facts & figures2013 2013, American Cancer Society, American Cancer Society, Atlanta.
5. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEngl J Med 1996, 334:693-699.
6. Wong R.J., Corley D.A. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci 2009, 54:2031-2039.
7. Andreou A., Vauthey J.N., Cherqui D., et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. JGastrointest Surg 2013, 17:66-77.
8. Schwarz R.E., Smith D.D. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008, 195:829-836.
9. Nathan H., Segev D.L., Mayo S.C., et al. National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancer 2012, 118:1838-1844.
10. Kemp W., Pianko S., Nguyen S., et al. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. JGastroenterol Hepatol 2005, 20:873-881.
11. De Luna W., Sze D.Y., Ahmed A., et al. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009, 9:1158-1168.
12. United Network for Organ Sharing. Available at: Accessed July 24,2013. http://www.unos.org.
13. Thuluvath P.J., Guidinger M.K., Fung J.J., et al. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010, 10:1003-1019.
14. Ioannou G.N., Perkins J.D., Carithers R.L. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008, 134:1342-1351.
15. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: SEER*Stat 8.0. National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, November 2012 submission. http://www.seer.cancer.gov.
16. International Classification of Diseases for Oncology 2000, World Health Organization, World Health Organization, Geneva, Switzerland. 3rd ed.
17. SEER summary staging manual: 2000-codes and coding instructions 2001, National Cancer Institute, Bethesda, MD. J.L. Young, S.D. Roffers, L.A.G. Ries (Eds.).
18. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. JClin Oncol 2009, 27:1485-1491.
19. Guiu B., Minello A., Cottet V., et al. A30-year, population-based study shows improved management and prognosis of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2010, 8:986-991.
20. Wong N., Haydon A., Kemp W., et al. Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009. Intern Med J 2013, 43:197-203.
21. Capocaccia R., Sant M., Berrino F., et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007, 102:1661-1670.
22. De Giorgio M., Vezzoli S., Cohen E., et al. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl 2010, 16:503-512.
23. El-Serag H.B., Mason A.C., Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001, 33:62-65.
24. Siegel A.B., Russell R.B., El-Serag H.B., et al. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol 2008, 103:120-127.
25. Robbins A.S., Cox D.D., Johnson L.B., et al. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007. Cancer 2011, 117:4531-4539.
26. Mathur A.K., Osborne N.H., Lynch R.J., et al. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg 2010, 145:1158-1163.
27. Ananthakrishnan A.N., Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol 2008, 103:901-910.
28. Artinyan A., Mailey B., Sanchez-Luege N., et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the U.S. Cancer 2010, 116:1367-1377.
29. Moylan C.A., Brady C.W., Johnson J.L., et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008, 300:2371-2378.
30. Ha B.Y., Ahmed A., Sze D.Y., et al. Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther 2007, 26:839-846.